Physician profile
Anne Robbins
NPI 1366897712
$934.07
in general payments reported to CMS, 2019-2025
12 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $396 · 2023: $54.96 · 2024: $62.03 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $244.63 | 2021-2025 | Lifevest |
| Medtronic, INC. | $192.60 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $160.43 | 2022-2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $86.56 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.36 | 2022-2023 | Jardiance |
| Scpharmaceuticals INC. | $37.79 | 2025 | |
| Abbott Laboratories | $29.14 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $24.41 | 2023 | Farxiga |
| Cvrx, INC. | $22.80 | 2024 | Barostim Neo System |
| Pfizer INC. | $20.06 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.46 | 2022 | |
| Recor Medical INC | $14.83 | 2025 | Paradise Ultrasound Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.